


Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform for Respiratory Health, RESP®
Philadelphia, PA May 3, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received...
Medtech Company, Strados Labs, Awarded National Science Foundation SBIR Phase II Grant
Funding will help Strados advance the power of its smart sensors to provide early detection and predictions of infectious respiratory diseases Philadelphia, PA, March 10, 2020 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine...
Strados Labs, Growing Medtech Company, Raises $4.5M in Pre-series A Funding Round
Funding to fuel next key milestones as company continues to target asthma, COPD and infectious respiratory diseases in 2022 Philadelphia, PA January 5, 2022 — Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and...
Procter & Gamble Health Care Veteran, Steve Bishop, Joins Strados Labs Board of Directors
Strados Labs harnesses the power of smart sensors and machine learning to aid in early detection and predictions of worsening respiratory diseases for enhanced patient care Philadelphia, PA, December 16, 2021 – Strados Labs, a medical technology company harnessing...
Recent Comments